P&I Clinical Research /ID# 161625 — Lufkin, Texas

P&I Clinical Research /ID# 161625 is a clinical research site located in Lufkin, Texas, United States 75904-3132.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

P&I Clinical Research /ID# 161625 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Rheumatoid Arthritis.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lufkin

Browse all research sites in Texas · View every site in Lufkin

• Texas Institute for Kidney and Endocrine Disorders
• Research Site
• GSK Investigational Site
• Novartis Investigative Site
• P&I Clinical Research
• The Heart Institute of East Texas
• Heart Institute of East Texas
• East Texas Nephrology Associates
• Private Practice
• Texas Inst, Kdny & Endo Disor
• TAD Clinical Research
• P&I Clinical Research /ID# 151358

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for P&I Clinical Research /ID# 161625?

P&I Clinical Research /ID# 161625 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has P&I Clinical Research /ID# 161625 conducted?

P&I Clinical Research /ID# 161625 has 1 clinical trials on record, with 1 currently active. Their work covers Rheumatoid Arthritis.

Is P&I Clinical Research /ID# 161625 accredited by Crixeo Clinical Trials?

P&I Clinical Research /ID# 161625 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about P&I Clinical Research /ID# 161625?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.